MDT-MEDTRONIC PLC

Medtronic Gears Up for Market Impact with Launch of Evolut FX+ TAVR Device and New Clinical Trials

Member Only Article

Monday

28 October, 2024

Medtronic is set to make waves in the medtech arena with the launch of its Evolut FX+ TAVR system, designed to enhance patient care for severe aortic stenosis. As the competition heats up, can Medtronic maintain its edge and navigate the evolving landscape effectively?

article image for MDT

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
0
Key Takeaways
  • Loading...

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.